FLUCONAZOLE THERAPY OF DISSEMINATED CRYPTOCOCCOSIS IN AIDS PATIENTS WITH LIVER-CIRRHOSIS

被引：2
|
作者：
CRUCIANI, M
DIPERRI, G
DANZI, MC
MAZZI, R
CONCIA, E
BASSETTI, D
机构：
[1] Institute of Infectious Diseases. University of Verona., Verona
来源：
MEDECINE ET MALADIES INFECTIEUSES | 1991年 / 21卷 / 07期
关键词：
FLUCONAZOLE; AIDS; DISSEMINATED CRYPTOCOCCOSIS; LIVER CIRRHOSIS;
D O I：
10.1016/S0399-077X(05)80148-9
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We report our experience with fluconazole in the treatment of disseminated cryptococcosis in 3 AIDS patients suffering for liver cirrhosis. All the patients were clinically cured. Fluconazole was well tolerated and no side effects were seen. Overall fluconazole seems to be an efficacious and safe agent for the treatment of cryptococcal infections, even in patients with liver impairment.
引用
收藏
页码：422 / 423
页数：2
相关论文
共 50 条
  • [21] SPECIAL PROBLEMS OF THE DIURETIC THERAPY IN PATIENTS WITH LIVER-CIRRHOSIS AND ASCITES
    GLEZER, GA
    KARDIOLOGIYA, 1994, 34 (7-8) : 85 - 89
  • [22] FLUCONAZOLE TREATMENT FOR CANDIDIASIS AND CRYPTOCOCCOSIS IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX
    GRITTI, FM
    RAISE, E
    BONAZZI, L
    VANNINI, V
    DIGIANDOMENICO, G
    LANZONI, G
    CUCCI, AM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 47 (06): : 1049 - 1062
  • [23] DISSEMINATED CRYPTOCOCCOSIS IN A PATIENT WITH AIDS
    REBLIN, T
    MEYER, A
    ALBRECHT, H
    GRETEN, H
    MYCOSES, 1994, 37 (7-8) : 275 - 279
  • [24] ALPHA-ANTIPLASMIN AND DISSEMINATED INTRAVASCULAR COAGULATION IN LIVER-CIRRHOSIS
    MARONGIU, F
    MAMUSA, AM
    MAMELI, G
    MULAS, G
    SOLINAS, A
    DEMELIA, L
    CONTU, L
    THROMBOSIS RESEARCH, 1985, 37 (02) : 287 - 294
  • [25] THE PHARMACOKINETICS OF JOSAMYCIN IN PATIENTS WITH LIVER-CIRRHOSIS
    OKOLICSANYI, L
    VENUTI, M
    ORLANDO, R
    IEMMOLO, RM
    NASSUATO, G
    MIGLIOLI, PA
    FESTA, A
    GROLLO, A
    BERTI, T
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1983, 9 (07) : 523 - 525
  • [26] PHARMACOKINETICS OF ZIDOVUDINE IN PATIENTS WITH LIVER-CIRRHOSIS
    TABURET, AM
    NAVEAU, S
    ZORZA, G
    COLIN, JN
    DELFRAISSY, JF
    CHAPUT, JC
    SINGLAS, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (06) : 731 - 739
  • [27] HEMOSTASIS ACTIVATION IN PATIENTS WITH LIVER-CIRRHOSIS
    VUKOVICH, T
    TEUFELSBAUER, H
    FRITZER, M
    KREUZER, S
    KNOFLACH, P
    THROMBOSIS RESEARCH, 1995, 77 (03) : 271 - 278
  • [28] FLEROXACIN PHARMACOKINETICS IN PATIENTS WITH LIVER-CIRRHOSIS
    BLOUIN, RA
    HAMELIN, BA
    SMITH, DA
    FOSTER, TS
    JOHN, WJ
    WELKER, HA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) : 632 - 638
  • [29] PHARMACOKINETICS OF METOPROLOL IN PATIENTS WITH LIVER-CIRRHOSIS
    JORDO, L
    REGARDH, CG
    ERVIK, M
    LUNDBORG, P
    OLSSON, R
    RONN, O
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (02) : 262 - 262
  • [30] PHARMACOKINETICS OF FAMOTIDINE IN PATIENTS WITH LIVER-CIRRHOSIS
    DUMAS, F
    BALDIT, C
    COUZIGOU, P
    BANNWARTH, B
    VINCON, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1993, 88 (06): : 971 - 972
12345